Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease

Chi-Fu Jeffrey Yang1, Michele Lee, Clarissa Valim

  • 1Harvard Medical School, Boston, MA 02115, USA.

Insights

Children with parenteral nutrition-associated liver disease (PNALD) often have persistent elevated alanine aminotransferase (ALT) levels, indicating ongoing liver injury even after direct bilirubin normalizes and they achieve enteral nutrition independence.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Clinical Nutrition

Background:

  • Parenteral nutrition-associated liver disease (PNALD) is a significant complication in children with short bowel syndrome.
  • Early identification and monitoring of liver injury are crucial for managing PNALD.

Purpose of the Study:

  • To longitudinally assess serum alanine aminotransferase (ALT) levels in children with PNALD who are transitioning to enteral nutrition.
  • To evaluate the correlation between ALT normalization and direct bilirubin levels in this cohort.

Main Methods:

  • Retrospective chart review of 31 pediatric patients with PNALD.
  • Analysis of patients who achieved full enteral nutrition tolerance after a minimum of 3 months of parenteral nutrition.
  • Kaplan-Meier and Cox proportional hazards methods were used to estimate time to normalization of ALT and direct bilirubin.

Main Results:

  • After transitioning to enteral nutrition, 74% of children normalized direct bilirubin, while only 50% normalized ALT.
  • Median time to direct bilirubin normalization was 13 weeks, compared to 35 weeks for ALT normalization (P = .001).
  • Persistent ALT elevation was observed in children with PNALD despite normalization of direct bilirubin.

Conclusions:

  • Children achieving enteral nutrition independence with PNALD may experience ongoing hepatic injury, as indicated by persistent ALT elevation.
  • ALT normalization lags behind direct bilirubin normalization, suggesting a prolonged recovery period for liver function.
  • This study highlights the importance of monitoring ALT beyond bilirubin levels in children recovering from PNALD.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...